CL
EXAS

Choreo LLC’s Exact Sciences EXAS Stock Holding History

Choreo LLC’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,873
Closed -$497K – 1643
2025
Q4 		$497K Buy
4,873
+967
+25% +$77.7K 0.01% 928
2025
Q3 		$214K Sell
3,906
-3,652
-48% -$182K ﹤0.01% 1423
2025
Q2 		$402K Sell
7,558
-625
-8% -$31.8K 0.01% 1011
2025
Q1 		$354K Sell
8,183
-895
-10% -$45.3K 0.01% 1016
2024
Q4 		$510K Sell
9,078
-1,360
-13% -$84.6K 0.01% 894
2024
Q3 		$710K Sell
10,438
-933
-8% -$52.7K 0.01% 732
2024
Q2 		$482K Buy
11,371
+7,903
+228% +$435K 0.01% 825
2024
Q1 		$240K Buy
+3,468
New +$219K 0.01% 590

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Choreo LLC's EXAS Position: Q1 2026 in Review

Choreo LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,873 shares — an estimated $497K sold.

Choreo LLC first reported a position in EXAS in Q1 2024 and held it in 8 quarters. The position peaked at $710K in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Choreo LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Choreo LLC sold 4,873 Exact Sciences shares in Q1 2026, an estimated $497K.
  • Choreo LLC first reported a position in Exact Sciences in Q1 2024 and held it in 8 quarters.
  • Choreo LLC's Exact Sciences position peaked at $710K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.